Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Mitchell
News Release
Evzio Naloxone Auto-Injectors Discontinued
Kaleo, the makers of Evzio, have recently discontinued the prod
Workers' Comp
News Release
Business Insurance: Lack of guidelines complicates COVID-19 care
Evidence-based medicine is a mainstay in the workers compensation industry, and those aiming to treat workers with COVID-19 are relying on an
Workers' Comp
Blog
Look for a Broken Spirit, Not Just a Broken Bone
As featured on the workcompwire.com blog, this piece was contributed by Tammy Bradly, Vice President, Clinical Product Develo
Mitchell
News Release
FDA Approves Veklury (Remdesivir) for Treatment of Hospitalized COVID-19 Patients
On October 22, 2020, the Food and Drug Administration (FDA)
Workers' Comp
Case Study
A Higher Calling
Catastrophic Case Management Meet Stephanie, CCM, RN Catastrophic case managers must be equipped t
Workers' Comp
Blog
Expertise and a Strong Specialty Network are Critical in Helping Injured Workers Recover from Opioid Use Disorder
What’s become clear from years of combating opioid use disorders is that, for most patients, recovery is difficult and often